These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7501932)

  • 21. Peptic ulcer recurrence and Helicobacter pylori: evidence from Japan.
    Tsuji S; Kawano S
    J Gastroenterol; 2003; 38(4):410-1. PubMed ID: 12743786
    [No Abstract]   [Full Text] [Related]  

  • 22. Helicobacter pylori infection in childhood: results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole.
    Nijevitch AA; Farztdinov KM; Sataev VU; Khasanov RSh ; Katayev VA; Khusnutdinov SM; Akhunov ED; Kazykhanov NS
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1243-50. PubMed ID: 11129216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H2-receptor antagonists an Helicobacter pylori eradication.
    Lamers CB
    Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of H. pylori infection: the reality.
    Vakil N
    Yale J Biol Med; 1998; 71(2):119-24. PubMed ID: 10378357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current criteria for the treatment of peptic ulcer].
    Díaz-Rubio García DM
    An R Acad Nac Med (Madr); 1996; 113(1):213-21; discussion 221-5. PubMed ID: 8967574
    [No Abstract]   [Full Text] [Related]  

  • 27. [Upgrading efficiency and safety of combined antihelicobacterial treatment of ulcer patients using modern clinicopharmacological approaches].
    Bezborodnyĭ SD
    Klin Med (Mosk); 2000; 78(9):44-7. PubMed ID: 11051740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Guidelines for good practice: anti-ulcer agents, indications in the adult. French Agency for Health Safety of Health Products].
    Therapie; 1999; 54(5):509-17. PubMed ID: 10667082
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome.
    Wheeldon TU; Hoang TT; Phung DC; Björkman A; Granström M; Sörberg M
    Aliment Pharmacol Ther; 2005 Apr; 21(8):1047-53. PubMed ID: 15813841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori.
    Meyer JM; Hopkins RJ
    N Engl J Med; 2003 Jan; 348(4):363-5. PubMed ID: 12540657
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic approaches to recurrent peptic ulcer disease.
    Cave DR
    Hosp Pract (Off Ed); 1992 Sep; 27(9A):33-40, 43, 47-9. PubMed ID: 1522168
    [No Abstract]   [Full Text] [Related]  

  • 32. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eradication of Helicobacter pylori followed by reinfection.
    Tonokatsu Y; Fukuda Y; Tsujiai T; Tamura K; Shimoyama T
    J Gastroenterol; 1996 Nov; 31 Suppl 9():75-6. PubMed ID: 8959526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH; Yeung CK; Lee KH
    Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
    Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes].
    Isakov VA
    Eksp Klin Gastroenterol; 2004; (3):40-4. PubMed ID: 15560400
    [No Abstract]   [Full Text] [Related]  

  • 38. "Modern therapies for Helicobacter pylori infection".
    Go MF
    Acta Gastroenterol Latinoam; 1996; 26(2):119-23. PubMed ID: 9137668
    [No Abstract]   [Full Text] [Related]  

  • 39. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of Helicobacter pylori infection.
    Meurer LN; Bower DJ
    Am Fam Physician; 2002 Apr; 65(7):1327-36. PubMed ID: 11996414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.